Medable, Inc

New capabilities. New measures. New possibilities. The next era has arrived ?? ??! This is progress… This is Medable ??! ________ Alison Holland, Michelle Longmire, Tim Smith, Andrew Mackinnon, Colin Weller, Pamela Tenaerts, MD, MBA, Cindy Howry, MS, Hady Khoury, Amar Jani, Marc Ginsky, Martin Cook, Deanna Coscia, Tyler Pugsley #clinicaltrials #clinicalresearch #healthcare #digitalhealth

???? Japan’s clinical trial landscape is one of the most complex in the world, with unique regulations, tech compatibility hurdles, and deep-rooted cultural nuances that impact patient engagement. But instead of seeing roadblocks, our team saw an opportunity to achieve new levels of excellence ??. By listening, localizing, and innovating, we transformed a sponsor’s study execution and delivery, and the results speak for themselves ??: 1) 90%+ site & patient adherence 2) Record-low help desk tickets 3) Faster first-patient-in (FPI) timelines How did we do it? Read the full story here ??: https://lnkd.in/ej-WknN2 ________ Michelle Longmire, Tim Smith, Alison Holland, Pamela Tenaerts, MD, MBA, David Geismar, Steve Jones, Hady Khoury #clinicaltrials #clinicalresearch #healthcare #digitalhealth

From patients to sites, from small biotech to global pharmaceutical organizations—the confidence around digitally enabled clinical trials is skyrocketing ??. And it's no longer just the inflated excitement that helped the industry solve problems during the COVID-19 pandemic. The technology works—now, it’s time to scale it ??. Learn from Medable's Andrew Mackinnon how we can bridge the gap between the industry’s innate cautiousness and patients’ need for speed ??. Read here: https://lnkd.in/ez7KJzH9 ________ Michelle Longmire, Tim Smith, Alison Holland, Pamela Tenaerts, MD, MBA, Steve Jones, Dave Orrico #clinicaltrials #clinicalresearch #healthcare #digitalhealth

The future of clinical trials is digital and decentralized—and it’s happening now! DCTs are making research more inclusive, efficient, and patient-friendly, but sponsors still face challenges like data variability, patient engagement, and regulatory complexity. In his recent blog, our Chief Data Officer Steve Jones explores: - How to balance data integrity with flexibility - Why no-code automation & AI-powered insights are key to accelerating studies - How Medable Studio is making DCTs transparent, simpler, and scalable ?? See what's next in drug development! Read more below ????. ________ #clinicaltrials #clinicalresearch #healthcare #digitalhealth #decentralizedtrials

"The approval covers two global trials in phase two and three, part of Servier’s development program. This meticulous process illustrates Medable’s high standards, showcasing our dedication to maintaining data protection while advancing clinical research methodologies. Our commitment to secure and efficient data handling set a benchmark for future endeavors." Andrew Mackinnon, SVP & Executive GM, Customer Value. Learn more here: https://lnkd.in/eiudHfkU ________ Michelle Longmire, Tim Smith, Pamela Tenaerts, MD, MBA, Steve Jones, Cindy Howry, MS Moe Alsumidaie, The Clinical Trial Vanguard #clinicaltrials #clinicalresearch #healthcare #lifesciences

?? Demo on-demand ??: Watch Jessica Dolfi create eCOAs in seconds—35X faster than other no-code solutions! Say goodbye to manual setup and hello to automation, real-time visibility, and total control. Medable Studio, now powered with Medable AI, rapidly delivers assessment screens of varying complexity and logic, ultimately accelerating your path to FPI. View the latest innovations here: https://lnkd.in/e-Xv9FnV ________ Michelle Longmire, Tim Smith, Alison Holland, Dave Orrico, Jon McClelland #clinicaltrials #clinicalresearch #healthcare #eCOA

When OpenAI unveiled ChatGPT in November 2022, it ignited unprecedented interest in artificial intelligence. Three years later, GenAI and machine learning have caused seismic shifts in industries worldwide. The pharmaceutical industry is not left out of this transformation, with Roots Analysis reporting that they expect AI within clinical trials to grow at a CAGR of 16% through 2035. Learn from key industry experts, including FDA AI policy leads, how the core aspects of drug development could be fundamentally reimagined using AI-powered solutions, from initial study design to final data analysis. Download our new free white paper to find out more: https://lnkd.in/e_gVMYsM ________ Michelle Longmire, Tim Smith, Hady Khoury, Steve Jones, Pamela Tenaerts, MD, MBA, Dave Orrico #clinicaltrials #clinicalresearch #AI #healthcare

French data privacy regulators have approved Medable’s electronic consent and eCOA technologies in a decision that will expand access for digital clinical trials across the European Union. “This approval shows that Medable not only has robust technical, security, and data protection capabilities but also the recognition that the collection of personal data provides a benefit to the study participants." Andrew Mackinnon, SVP & Executive GM, Customer Value. Read more here: https://lnkd.in/eDvMjsBr ________ Michelle Longmire, Tim Smith, Pamela Tenaerts, MD, MBA, Steve Jones, Alison Holland #clinicaltrials #clinicalresearch #healthcare #digitalhealth

Think different.

??From improving data quality to enhancing patient experience, the right eCOA partner makes all the difference. Our latest guide breaks down how leading vendors are shaping the future of decentralized trials and what to look for when choosing a partner. ?? Get the insights here: https://lnkd.in/ekka88xg #ClinicalTrials #DecentralizedTrials #eCOA #Innovation #Medable